Relay Therapeutics, Inc. RLAY Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s total revenue?
- Relay Therapeutics, Inc. (RLAY) reported total revenue of $3M in Q1 2026.
- How has Relay Therapeutics, Inc.'s total revenue changed year-over-year?
- Relay Therapeutics, Inc.'s total revenue decreased by 60.9% year-over-year, from $7.68M to $3M.
- What is the long-term trend for Relay Therapeutics, Inc.'s total revenue?
- Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s total revenue has grown at a 50.1% compound annual growth rate (CAGR), from $3.03M to $15.36M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.